20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78870 | TWIK-1/TREK-1-IN-3 | Potassium Channel | |
TWIK-1/TREK-1-IN-3 is a selective and potent inhibitor of potassium channel TREK-1, inhibiting TREK-1 homodimers and TWIK-1/TREK-1 heterodimers containing two-pore-domain potassium (K2p) channels.TWIK-1/TREK-1-IN-3 exhib... | |||
T37709 | 2,2,2-Trichloroethanol | Potassium Channel , Endogenous Metabolite | |
2,2,2-Trichloroethanol, the active form of the sedative hypnotic drug chloral hydrate, is an agonist for the nonclassical K2P channels TREK-1 (KCNK2) and TRAAK (KCNK4)[1]. 2,2,2-trichloroethanol activates a nonclassical ... | |||
T78868 | TWIK-1/TREK-1-IN-1 | Potassium Channel | |
Compound 2a, identified as TWIK-1/TREK-1-IN-1, acts as an inhibitor of the TREK-1, a two-pore domain potassium channel (K2p) that forms TREK-1 homodimers and TWIK-1/TREK-1 heterodimers, both significant for its role as a... | |||
T78869 | TWIK-1/TREK-1-IN-2 | Potassium Channel | |
TWIK-1/TREK-1-IN-2 (Compound 2g) serves as an inhibitor of both TWIK-1 and TREK-1, targeting the TREK-1 homodimer and TWIK-1/TREK-1 heterodimer with IC50 values of 10.13 μM and 15.5 μM, respectively. Additionally, it exh... | |||
T0386L | Ropivacaine | LEA-103 HCl | Potassium Channel , Sodium Channel |
Ropivacaine (LEA-103 HCl) is a local anaesthetic drug belonging to the amino amide group. | |||
T0386 | Ropivacaine hydrochloride | Ropivacaine monohydrochloride | Potassium Channel , Sodium Channel |
Ropivacaine hydrochloride (Ropivacaine monohydrochloride) is the hydrochloride salt of ropivacaine, a local anesthetic of the amide type with analgesic activity. | |||
T6645 | Ropivacaine hydrochloride monohydrate | Ropivacaine HCl,Ropivacaine HCl monohydrate,LEA 103,LEA-103 HCl | Potassium Channel , Sodium Channel |
Ropivacaine hydrochloride monohydrate (LEA-103 HCl) is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly. | |||
T4224 | ML335 | Potassium Channel | |
ML335 is a selective activator of TREK-1 and TREK-2. | |||
T16109 | ML402 | ZINC3671497,N-[2-(4-chloro-2-methylphenoxy)ethyl]thiophene-2-carboxamide | Potassium Channel |
ML402 (ZINC3671497) is an activator of TREK-1 and TREK-2 with EC50s of 13.7 μM and 5.9 μM. | |||
T22178L | Spadin Acetate | Spadin Acetate(1270083-24-3 Free base) | Others |
Spadin Acetate is a natural peptide derived from a propeptide released in blood. Spadin Acetate is able to block the TREK-1 channel activity. Spadin Acetate binds specifically to TREK-1 with an affinity of 10 nM. | |||
T8700 | TKIM | Potassium Channel | |
TKIM is a TWIK-related potassium channel 1 (TREK-1) inhibitor, binding to the pocket of the intermediate (IM) state of TREK-1. | |||
T14666 | BL-1249 | Potassium Channel | |
BL-1249 is a selective and potent non-steroidal potassium channel activator with anti-inflammatory activity that activates K2P2.1 (TREK-1) and K2P10.1 (TREK-2). | |||
T67917 | ML353 | VU0478006 | Potassium Channel |
ML353 (VU0478006) is a selective activator of TREK-1 and TREK-2 and a selective ligand (Ki =18.2 nM) for the mGlu5 Silencing Allosteric Modulator (SAM). ML353 has potential as a solution to the intrinsic activity or phar... | |||
T7774 | A2793 | Potassium Channel | |
A2793 is a dual inhibitor of TWIK-associated acid-sensitive K+ channel 1 (TASK-1)/TRESK, with an IC50 for mTRESK of 6.8 μM. It is more selective for TRESK, and relatively weaker for TREK-1 and TALK-1. | |||
T7775 | A2764 dihydrochloride | Potassium Channel | |
A2764 dihydrochloride is a highly selective inhibitor of TRESK. | |||
T16112 | ML67-33 | HIV Protease | |
ML67-33 rapidly and reversibly affects K2P2.1 (TREK-1) (EC50s: 36.3 μM and 9.7 μM in cell-free and HEK293 cells, respectively). ML67-33 is a selective activator of temperature- and mechano-sensitive K2P channels. | |||
T71955 | C3001a | ||
C3001a is a selective activator for TREK, against other two-pore domain K+(K2P) channels. C3001a binds to the cryptic binding site formed by P1 and TM4 in TREK-1. C3001a targets TREK channels in the peripheral nervous sy... | |||
T76311 | PE 22-28 | ||
PE 22-28, a TREK-1 inhibitor exhibiting an IC50 value of 0.12 nM, is a 7 amino-acid peptide. It serves as a foundational sequence for the creation of analogs through chemical modifications and amino-acid substitution. Th... | |||
T75944 | Spadin TFA | ||
Spadin TFA, a natural peptide originating from a propeptide in blood, acts as a powerful TREK-1 channel inhibitor with an IC 50 of 10 nM. It boosts dorsal raphe nucleus 5-HT neurotransmission in mice, activates hippocamp... | |||
T71852 | Lig4-4 | ||
Lig4-4 is a TREK-1 current inhibitor (IC50 = 2.06 μM) that has demonstrated potential for use as a protective agent against cerebral ischemia. It has been postulated that the neuroprotective effects of Lig4-4 against cer... |